Compare ALXO & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALXO | CPSS |
|---|---|---|
| Founded | 2015 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.8M | 210.7M |
| IPO Year | 2020 | 2010 |
| Metric | ALXO | CPSS |
|---|---|---|
| Price | $1.67 | $9.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 941.0K | 23.6K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.36 | 1.27 |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $434,470,000.00 |
| Revenue This Year | N/A | $147.09 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $39.50 |
| Revenue Growth | N/A | ★ 10.41 |
| 52 Week Low | $0.41 | $6.67 |
| 52 Week High | $2.66 | $10.49 |
| Indicator | ALXO | CPSS |
|---|---|---|
| Relative Strength Index (RSI) | 35.80 | 42.45 |
| Support Level | $1.54 | $7.55 |
| Resistance Level | $2.24 | $9.58 |
| Average True Range (ATR) | 0.11 | 0.31 |
| MACD | -0.04 | -0.13 |
| Stochastic Oscillator | 2.38 | 12.36 |
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.